Data as of Jul 30
| +1.88 / +3.93%|
The 2 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 57.00, with a high estimate of 60.00 and a low estimate of 54.00. The median estimate represents a +14.57% increase from the last price of 49.75.
The current consensus among 3 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.